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Absorption and circular dichroism (CD) studies were performed 
on deoxy-HbA in the presence of various antisickling agents. In 
the presence of methylurea and butylurea, the absorption and CD 
studies on deoxy-HbA showed small changes at the absorption and CD 
maxima. However, the extent of these changes caused by the alky- 
urea could not be determined since experiments using the same HbA 
batch solution with the same amount of sodium dithionite added to 
it in different cells caused small differences at the absorption 
maxima. When sodium cyanate was added to deoxy-HbA at a concentra¬ 
tion ratio ([NaCNoj/[deoxy-HbA]) of 1000 or greater, the deoxy-HbA 
peak at 430nm shifted to 4l9nm and two peaks at 5^-Onm and 570nm 
appeared in the absorption spectrum. In the CD spectrum, peaks 
appear at 420nm in the Soret region and at 530nra and 570nm in the 
visible region when the NaCNO:deoxy-HbA concentration ratio equals 
5000. 
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INTKOlîUCTIüN 
Sickle cell anemia was first described as a molecular disease 
by Pauling in 1949. His observation was based on the fact that 
sickle cell hemoglobin (HbS) had a different electrophoretic 
mobility than normal hemoglobin (HbA).'L Since then, numerous 
investigations have been made on various aspects of the disease. 
Chemical investigation by Ingram had shown that HbS has a valine 
residue at the sixth position in the J5 chain instead of a glutamic 
2 
acid residue as in HbA. The subsitution of valine for glutamic 
acid causes the erythrocytes to aggregate to form well-ordered 
fibers or microtubules leading, in vivo, to the sickle cell crises 
and in vitro, to gelation at high concentration in the deoxygenated 
state.Although the basic geometry of the fibers is known from 
X-ray and electron microscopy, there is still no understanding as 
to why the fibers cause the sickle cell crises,^ 
This disease is transmitted genetically and it occurs in 
nearly every country of the world affecting mostly Blacks. In the 
United States alone, one out of every ten Blacks has the sickle 
cell trait while one in four hundreds has sickle cell anemia. 
Persons who have the trait show no clinical manifestation of the 
disease, and they live a normal life. But, persons with sickle 
cell anemia have less than a 50chance of attaining adulthood 
with the greatest mortality occurring before the age of ten and 
the principal cause of death being infection. 
There is still no successful clinical treatment of the disease 
1 
Z 
even though certain drugs are found to reverse or prevent the 
sickle cell crises. Cerami and Manning reported that cyanate 
prevents sickling.^1 This drug inhibits the sickling process by 
increasing the oxygen affinity of HbS. However, the clinical 
tests of cyanate showed it to be very toxic causing polyneritics 
and cataracts. Furthermore, several other reagents have been 
found to prevent sickling, but their potential side effects 
prevent them from being used in the clinical treatment of sickle 
cell anemia. 
Structure Of Hemoglobin 
Although the study of the three dimensional structure of 
human hemoglobin is limited, the three dimensional structure of 
horse hemoglobin has been determined in great detail from X-ray 
crystallography. Since human and horse hemoglobin have similar 
amino acid sequence, the three dimensional structure of the two 
is believed to be almost identical.^ 
The hemoglobin molecule is a tetramer of four polypeptide 
chains. The tetrameric structure consists of two alpha and two 
beta type chains. There are 141 amino acid residues in the d- 
chain while the ^-chain contains 14-6 amino acid residues. Table I 
shows the amino acid composition of the two chains. In the en¬ 
chain, 50/5 of the amino acid residues are nonpolar and in the J3- 
chain 43/5 of the amino acid residues are nonpolar. For Hb3, there 
3 
Table I. AMINO ACID COMPOSITION OF THE of AND ^.-CHAINS OF HbA 
Amino Acids Chains 
Nonpolar ft 
Ala 21 15 
lie 0 0 
Leu 18 18 
Met 2 1 
Phe 7 8 
Pro 7 1 
Trp 1 2 
Val 13 18 
Polar (Uncharged) 
Asn 4 6 
Cys 1 2 
Gin 1 3 
Gly 7 13 
Ser 11 5 
Thr 9 7 
Tyr 3 3 
Negatively Charged 
Asp 8 7 
Glu 4 8 
Positively Charged 
Arg 3 3 
His 10 9 
Lys 10 9 
Percent Nonpolar’ 50 43 
Total Residues 141 146 
y 
is one less glutamic acid (glu) residue and one more valine (val) 
residue per ^-chain at the sixth position. 
The amino acids are covalently linked to one another by 
peptide bonds and they constitute the primary structure of hemo¬ 
globin. A peptide bond is formed when an c(-carboxyl group of one 
amino acid combines with an a-amino group of another amino acid 
0 
(Fig. la). This bond distance is 1.32 A (Fig. lb) which corre¬ 
ct 
sponds to nearly 50 per cent double bond character. The 
unusally short bond distance for C-N is due to resonance inter¬ 
action between the 0=0 double bond and the C-N single bond. Because 
of this interaction, the peptide group is planar. 
Since the peptide bond has some double character, it is 
not free to rotate about its axis. This constrains the number of 
possible orientations that may occur in a polypeptide chain. But, 
rotation occurs about the c(-carbon bond connecting two peptide 
bonds in a polypeptide chain. The angle of rotation at the C*-N 
bond is represented by the angle 0 and the angle of rotation at 
the Co(-C bond by y (Fig. 2). The angles 0, y can take all the 
values from 0ûto 360°, however, not all combinations of values for 
0, y are sterically possible. Certain angles of ,0, f bring atoms 
too close together. Therefore, these angles of rotation are 
dictated by the attempt to minimize steric hindrance and maximize 
stability between neighboring groups, thus placing a limitation 
on the allowed rotation of the angles 0 and y. 
























Figure la. The formation of a peptide bond. The tf-carboxyl acid 
group of valine combines with the o<-amino group of histidine to 
form the dipeptide Val-His. 
Figure lb. Dimensions of a peptide group. The peptide bond 
corresponds to nearly 50 per cent double-bond character. The 
peptide group is planar. Figure from reference 9. 
6 
Figure 2, The angles (5 and y between two adjacent peptide groups. 
Angles 0 and y can takes values from 0°to 360? This is the standard 
conformation, p=0° and ^=0°. Figure from reference 10. 
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falls naturally into a helical structure. /in important stabilizing 
factor in this structure is hydrogen binding between the carbonyl 
group of one peptide bond and the amide group of another. Further¬ 
more, 80fo of the length of the polypeptide chains of hemoglobin is 
in the helical configuration.^ This consitutes the secondary 
structure of hemoglobin. 
The secondary structure of hemoglobin consists of three 
different types of helix (Fig. 3).^ The first type is the o(- 
helix. It has 3.6 amino acid residues per turn about the helix 
0 
axis with a 1.50 A translation movement along the axis and 0=133.0, 
4=122.8.10 The second type is the 31g~helix. It has 3.0 amino 
O 
acid residues per turn with a 2.00 A translation movement along 
the axis and 0=130.7» 4=154.3.10 The third type is the Tr-helix. 
o 
It has 4.4 amino acid residues per turn with a 1.15 A translation 
movement along the axis and 0=122.9, 7=110.3 
The polypeptide chains of hemoglobin are composed of several 
helical segments. Letters A to H are used to designate the heli¬ 
cal segments. Helical segments are separated from each other by 
nonhelical portions and they are designated by the letter of the 
adjoining helices. The nonhelical portions cause the main chain 
to fold back on itself. This specific folding pattern of the chain 
is the tertiary structure of hemoglobin. The folding pattern is 
influenced by several factors. Certain amino acids, eg., proline, 
disrupt the helical configuration and force the chain to turn a 
1 O 
comer or fold back. However the forces which appear to be 

9 
mainly responsible for the folding pattern are due to hydrophobic 
interactions. These interactions occur when nonpolar amino acid 
residues of the protein are exposed to a polar solvent, water. 
The driving forces for this type of interaction are a decrease in 
free energy and a gain in entropy. When a hydrophobic side 
chain is removed from an aqueous to a nonpolar environment, there 
T p 
is a decrease in free energy of about 4 kcal/mole. 
Seven helical segments consistute the (X-polypeptide chain of 
hemoglobin.11 The A segment is a regular right-handed oc-helix with 
the final turn forming a 3j_Q-helix. The same is also true for 
helices G and H while E is an irregular helix with the last turn 
forming a 31g-helix. The last turn of helix F is a /T-helix. Seg¬ 
ment C has a conformation of a 310-helix while B is a right-handed 
d-helix and segment D is absent. The J#-chain has eight helical 
segments. Segments A and H are both a regular right-handed d- 
helix with a conformation similar to the (X-chain. Helices B and D 
have conformations similar to segment B of the o<.-chain. Segment C 
has a 3-j_Q-helix conformation and the last turn of segment F is a 
h-helix. The last three residues in helix E form an irregular 
helix and the three residues in the begining of helix G form a 31Q 
conformation. Also, there are eight nonhelical regions which sepa¬ 
rate the helical segments, including two tails, one at the N- 
terminal, HA, and at the C-terminal, HO. 
The spacial arrangement of the four chains which form the 
hemoglobin molecule constitues the quaternary structure of 
10 
hemoglobin. An approximation of this arrangement is that the two 
cX-chains are side by side. The two /4-chains again side by side are 
on top of the a-chains, but they are inverted and rotated 90° 
relative to the o(-chains (Fig. 4). Between the four chains, there 
is a central cavity with a depth of 50 A, a width of 20 A at the 
C 
center and 10 A at the bottom and top of the cavity that separates 
like chains.A two-fold axis of symmetry passes down the cavity. 
The overall shape of the molecule resembles a spheriod with a 
length of 64 A, width of 55 A, and a height of 50 A."^ 
The arrangement of the chains is in such a way that there is 
close, interlocking contact of side groups between unlike chains 
but virtually no contact between like chains. Contacts occur 
between chains with neighboring hemes or ^2^1^ ^)e'*:ween 
chains with widely separated hemes or o^/^). The o^/?^ 
contact is more extensive than the contact. The d^l contact 
is made up of 34 residues with 110 atoms coming within a distance 
o 11 
of 4 A of each other. In this contact, there are five hydrogen 
bonds and the other interactions are hydrophobic. Residues lying 
between helices G and H (G10 thru H9) make up the majority of the 
contacts formed by these two chains. The o( /? contact is made up 
o ] ] 
of 19 residues and 80 atoms coming within a distance of k A. 
All interactions are nonpolar except for one hydrogen bond. 
Residues in helices G and G and in the nonhelical segments make 
up the majority of the contact. 
The quaternary structure of hemoglobin has two different 
11 
1 
Figure k. The spacial arrangement of the four chains. The letters 
A to H are used to designate the helical segments.o The hemoglobin 
molecule resembles a spheriod with a length of 6k Â, width of 55 À, 
and a height of 50 A. [As drawn from Dickerson, R. E., and Geis, I. 
(1969)» The Structure and Action of Proteins, New York, Harper & 
Row, p 56J 
12 
conformations, ie., the oxygenated and deoxygenated forms. In the 
transition from oxy- to deoxyhemoglobin, there is movement among 
the 0(^/9 012.^2 coni'ac'ks • ^ The movement in the contact is 
slight in comparison with the contact movement. In the 
contact, the Æ subunit rotates 3.7°about a screw axis and moves 
0.3 A along it relative to the cx^ subunit. The subunit in the 
^1^2 con‘^ac'*: rotates 13.5° about a screw axis and moves 1.9 A along 
it relative to the subunit. The displacement of atoms in the 
o o 
transition is about 1.0 A m the cx^^l con'tact and 5*7 A in the ^2^2 
contact. Also, the °dj_^2 is closely connected to the heme 
group so that any changes in the area of contact would affect the 
heme environment. 
In the transition from oxy- to deoxyhemoglobin, salt bridges 
are formed between the two o(-chains. There is a salt bridge be¬ 
tween the carboxyl group of the C-terminal arginine of one mf-chain 
and the free amino group of the N-terminal valine of the opposite 
cX-chain; and a bridge is between the guanidinium group of the C- 
terminal arginine and the side chain carboxyl group of aspartic 
acid (H9) in the opposite o(-chain. Because of the molecule's sym¬ 
metry, there are a total of four salt bridges in deoxyhemoglobin. 
Lying in the hydrophobic pockets of the <X and ^-chains are 
the heme groups. The heme group consists of a porphyrin ring with 
the central position occupied by an irom atom (Fig. 5). For a low 
spin iron atom, the iron lies in the plane of the porphyrin ring, 
while a high spin iron atom lies out of the plane.^ The iron atom 
is covalently 'bonded to a histidine group at position 8 in helix 
F. In addition to this linkage there are about sixty interactions 
between atoms of the globin chains and atoms of the porphyrin ring 
coming to within 4 A of each others; and all but a few are hydro- 
between a propionic acid carboxyl group with histidine CD3. Two 
polar contacts occur in the /^-chain. One is between a propionic 
acid carboxyl group and serine CD3• Another is between a second 
propionic acid carboxyl group and lysine E10. Thus, the iron 
atom is in a nonpolar environment and this characteristic permits 
the reversible binding with molecular oxygen. Also, the presence 
of the heme group is an important stabilizing factor on the globin 
12 
configuration. 
Figure 5» The structure of the heme group. The heme group con¬ 
sists of a porphyrin ring with an iron atom occupying the central 
position. 
o 
phobic interactions. "1 One polar contact occurs in the o(-chain 
14 
Function Of Hemoglobin 
One important function of hemoglobin is it ability to combine 
reversibly with oxygen. The degree of saturation of hemoglobin 
with oxygen is a function of the partial pressure of the gas. 
Oxygen is taken up readily in the lungs where the partial pressure 
is high and is released readily at low pressure as exists in the 
tissues. 
Oxygen binds to the iron atom in the sixth position of all 
four heme groups. Each successive oxygen molecule bound affects 
the binding of the next. This cooperative effect is shown in a 
sigmoid binding curve when the extent of oxygen binding is plotted 
against oxygen tension. A sequential and a symmetry model are used 
to explain the cooperative binding of oxygen to hemoglobin. The 
sequential model assumes that binding one molecule of oxygen to 
the high-affinity form on one subunit draws the remaining subunits 
to the high-affinity form when they bind oxygen sequentially. The 
symmetry model assumes that binding two molecules of oxygen pulls 
the equilibrium so that all the subunits are in the high-affinity 
form. The successive binding ratio of oxygen to hemoglobin is 
1s4 »24:9. The binding of oxygen to hemoglobin also causes a change 
in the quaternary structure from the deoxy to the oxy form. On 
oxygenation, the movement of the /«'-chains is more pronounced than 
that of the ^-chains. The large movement of the -^-chains causes 
the distance between the heme groups of the two chains to decrease 
15 
O 
by 6.5 A, Y/hile the heme group distance m the (X-chains increases 
by 1.0 A (Table II). This change in the subunit structure modifies 
the contact between the four chains so that the contact region be¬ 
tween the and /3^-chains remains practically unchanged v/hile the 
region between the and ^-chains shov/ a relatively large 
difference. 
Table II. DISTANCES BETWEEN IRON ATOMS IN DEOXY- AND OXYHEMOGLOBIN* 
Deoxyhemoglobin Oxyhemoglobin 
(A) (A) 
Fel-FeZ 1 4, 39.9 33.4 
Fe3-Fe^ u2~dl 34.9 36.0 
Fe1-Fe^ *z-#i 
^4.7 25.0 
Fe2-Fe4 a1-ez 24.6 25.0 
Fex-Fe4 «—1 
1$ 36.9 35.0 
Fe^-Fe^ 36.9 35.0 
*See ref. 12. 
A change in the spin state of the iron atom from high to low 
spin occurs v/hen oxygen binds to hemoglobin. In deoxyhemoglobin, 
the iron atom is formally ferrous (d^) and out of the porphyrin 
plane. When it combines reversibly with oxygen, a partial transfer 
. 14 of an electron occurs from the ferrous iron to the oxygen molecule. 
16 
By losing an electron, the iron atom has become ferric. The smaller 
ferric iron atom now lies in the plane of the porphyrin ring, ie., 
His F8 His F8 




By gaining an electron, the oxygen molecule has become a bound 
14 
superoxide anion (*00-). In a hydrophobic environment, the super¬ 
oxide anion is a stable species. The ferric ion is smaller than 
the ferrous, and the superoxide anion is larger than the oxygen 
molecule. These size changes might induce the conformational changes 




Absorption is based on Beer-Lambert's equation» 
I=Ioe-*b0 
where IQ is the intensity of incident light, I is the intensity of 
the transmitted light, <x is the absorption coefficient of the mate¬ 
rial, and b is the thickness of the absorbing material. The ratio 
l/lQ is related to the absorbance (A)» 
A=-Lo g1Q ( l/lQ )= E bC 
where I is the intensity of light transmitted by a suitable refer¬ 
ence solution, b is the pathlength of the solution, 8 is the molar 
extinction coefficient, and C is the concentration of the solution. 
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A plot of absorbance versus wavelength gives an absorption spectrum. 
For HbA, the peaks in the region between 400nm to 700nm are 
due to the heme group. Oxyhemoglobin has one peak in the Soret 
region at 4l5nm and two peaks in the visible region at 5^ Inn and 
577nm. Deoxyhemoglobin has one peak in the goret region at 430nm 
ana one peak in the visible region at 555nm. The Soret peak is 
essentially a TT-îr transition between molecular orbitals largely 
localized on the porphyrin while the peaks in the visible region 
have some charge transfer character betv/een the porphyrin and the 
iron atom.1^ 
Circular Dichroism 
Plane polarized light can be resolved into two circulary 
polarized components (left and right). When circularly polarized 
light passes through an optically active material, one component 
will absorb to a greater extent than the other. This unequal 
absorption results in elliptical polarized light. The ellipticity 
per unit length is defined as the angle whose tangent is the ratio 
of the minor axis to the major axis. The ellipticity is also pro¬ 
portional to the difference in the extinction coefficients of the 
two components (6r> ) of circularly polarized light. The following 
equation relates the two: 
[©>3300 ( Er £r )=3300A £ 
where [0] is the molar ellipticity. A plot of [Qf] versus wavelength 
will give a circular dichroism (CD) spectrum. 
The adsorption band can be characterized by its rotational 
strength, R. It is the inner product of two vectors, the electric 
(M) and magnetic (in) transition dipole moments. The rotational 
strength is given by the equations 
R=I_ (xX'm ) m 
where I refers to the imaginary part of the scalar product of the 
two vectors. If the electric and magnetic transition dipole moment 
vectors are parallel, R is positive. If they are antiparallel to 
each other, R is negative. R is zero if they are perpendicular. 
A CD band is observed when the absorption occurs in an asym¬ 
metric electrostatic field. In proteins, there are three types of 
asymmetry that can lead to optical activity. One type is the in¬ 
herent asymmetry of the protein. A second type is the mixing of 
transitions when a chromophore is placed in an asymmetric electro- 
■K- 
static field, ie., the mixing of the n-?r and d-d transition states 
permits the magnetically-allowed and electrically-forbidden tran¬ 
sitions to acquire electric dipole strength and become optically 
active. This is known as the one electron mechanism. The third 
is the coupling of the electric dipole transition in one group with 
the magnetic dipole transition moment in another group. 
The CD extrema of oxygenated and deoxygenated hemoglobin 
correspond in wavelength with the absorption maxima. Deoxygenated 
hemoglobin exhibits two positive CD peaks at 552nm and 590nm in the 
visible region while the absorption spectrum shows only one peak at 
19 
555nm in this region. The CD band at 590nm appears to be a small 
shoulder on the absorption spectrum. In this region, the CD 
A 
spectrum shows a greater resolution than the absorption spectrum. 
The CD extrema in the region between 4-OOnm to 700nm are due to the 
heme group. The heme group has only electric dipole transition 
moments in the porphyrin plane.1 In order for the heme group to 
have CD bands, it must has both electric and magnetic transition 
dipole moments. It obtains a magnetic dipole transition moment 
■îr 
by the coupled oscillator interaction with the Tr-Tr transitions 
of the aromatic side chains (including histidines). 
Antisickling Agents 
If a compound inhibits the sickling process, it must raise 
the minimum gelling concentration (MGC) of deoxy-HbS or prevent 
deoxy-HbS from gelling. Compounds can inhibit the sickling process 
either by noncovalent interaction with hemoglobin or by binding 
covalently to the hemoglobin molecule. 
The noncovalent inhibitors used are from a family of compounds 
called alkylureas. They inhibit the sickling process in direct pro¬ 
portion to the length of the hydrocarbon chain.1'7 Two alkylureas 
were used in this study, methylurea (CH^-NH-CO-ilu^) and butylurea 
(CH^ (CH^-HH-CO-Nï^). Methylurea at a concentration of 0.1 M raises 
the MGC of deoxy-HbS 4 g/dl (gram/deciliter). A 0.1 M solution of 
butylurea raises the MGC of deoxy-HbS 10 g/dl. The covalent in- 
20 
hibitor used was sodium cyanate (NaCMQ). Gyanate covalently binds 
to the NH2-terminal valine residues of hemoglobin.^ The reaction 
is given belowi 
R-NH2 + HH=C=0  -> R-KH-CG-NH2. 




Buffer Solution? The Buffer solution consisted of 0.1 M Tris- 
HC1 plus 1.0 mM EDTA at a pH of 7*0. One liter of the buffer 
solution was prepared by weighing out 12.114 grams of the primary 
standard THAM (tris hydroxymethyl aminomethane) and 0.29225 grams 
of EDTA (ethylene-diamine-tetra-acetic-acid). The THAM and EDTA 
were dissolved in about 700 ml of distilled water. The pH of the 
solution was adjusted to a value of 7*0 by adding concentrated 
HG1. The solution v/as then diluted to the mark with distilled 
water in a 1000 ml Pyrex volumetric flask (for error analysis 
see appendix). 
Hemoglobin Solution (stock): The solution was prepared from 
crystalline human HbA which was obtained from Sigma Chemical 
Company. The crystalline HbA was 75c/° met-HbA. By using sodium 
dithionite, the met-HbA was converted into deoxy-HbA. A stock HbA 
solution was prepared by dissolving 0.1 gram of crystalline HbA 
in 50 ml of the buffer solution. The stock solution v/as stored 
under refrigeration at about 4 C. The concentration of the stock 
HbA solution was determined spectrophotometrically. Using a 3.0 
ml Fisher brand pipet, 3.0 ml of the stock HbA solution v/as pipetted 
into a clean dry 1.0 cm cell. 0.003 grams of sodium dithionite 
were weighed out and added to it. The top v/as immediately placed 
on the cell and it was shaken until all of the sodium dithionite 
21 
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dissolved in the solution. After thirty minutes, the absorption 
was measured at 555nm. Using a molar extinction coefficient of 
5.0 x 104, the concentration was determined from the equation 
A=6Cb where G is the concentration in mole/liter (for error 
analysis see appendix),^ 
Antisickling Agents» A 1.0 mM, 50 mil, and 0.5 M solution of 
each antisickling agent was prepared in the tris-EDTA buffer (for 
error analysis see appendix). The antisickling agents were obtained 
from Aldrich Chemical Company. A 1.0 mM solution of methylurea, 
97'-/o, was prepared by weighing out 0.01852 grams and dissolving it 
in 100 ml of the buffer solution. The solution was then diluted 
to the mark with the buffer solution in a 250 ml volumetric flask 
(Pyrex). A 50 mil solution was prepared by weighing out 0.18520 
grams and dissolving it in 50 ml of the buffer solution in a 50 
ml volumetric flask. A 0.5 M solution was prepared by weighing 
out 0.926 grams and dissolving it in 25 ml of the buffer solution 
in a 25 ml volumetric flask. Butylurea at a concentration of 1.0 
mM was prepared by weighing out 0.01162 grams and dissolving it 
in 100 ml of the buffer solution in a 100 ml volumetric flask. A 
50 mM solution was prepared by weighing out 0.29040 grams and 
dissolving it in 50 ml of the buffer solution in a 50 ml volumetric 
flask. A 0.5 M solution was prepared by weighing out 2.904 grams 
and dissolving it in 50 ml of the buffer solution in a 50 ml 
volumetric flask. A 1.0 mM solution of sodium cyanate, 97'/, was 
prepared by weighing out 0.01625 grams and dissolving it in 250 ml 
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of the buffer solution in a 250 ml volumetric flask. A 50 mM 
solution was prepared by weighing out 0.16253 grams and dissolving 
it in 50 ml of the buffer solution in a 50 ml volumetric flask. A 
0.5 M solution was prepared by weighing out 0.81262 grams and 
dissolving it in 25 ml of the buffer solution in a 25 ml volumetric 
flask. 
Solution For Spectral Studies 
Blank Solution: This was prepared by pipetting 3.0 ml of the 
buffer solution into a clean dry cell. 0.003 grams of sodium 
dithionite were weighed out and added to it. The top was immedi¬ 
ately placed on the cell. 
Deoxy-HbA Solutions A I.OAJIM and 10 XAM HbA solution was 
prepared in a 10 ml volumetric flask (Pyrex) from the stock HbA 
solution (for error analysis see appendix). The concentration of 
the stock HbA solution was determined spectrophotometrically. From 
a 24.4 xU1-'I stock HbA solution, a 1.0 AM HbA solution was prepared 
by pipetting 0.41 ml of the solution into a 10 ml volumetric flask 
using a 1 ml in l/lOO pipet (Fisher brand). The solution was 
diluted to the mark with the buffer solution. A 10 xcl.l HbA solution 
was prepared by pipetting 4.1 ml of the stock solution in a 10 ml 
volumetric flask using a 5 nil in l/lO pipet; and the solution was 
diluted to the mark with the buffer solution. Deoxygenation was 
performed by pipetting 3*0 ml of the 1.0 JULM or 10 IKU HbA solution 
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into a clean dry 1.0 cm cell. 0.003 grams of sodium dithionite 
were weighed out and added to it. The top was immediately placed 
on the cell and it was shaken until all of the sodium dithionite 
dissolved in the solution. In some cases, sodium dithionite was 
added to the cell under a nitrogen atmosphere to eliminate the 
contact with air. 
Deoxy-HhA plus the Antisickling Agent Solution! A deoxy-HbA 
plus antisickling agent solution at a ratio of 1 to 1 (1 deoxy- 
HbA to 1 jtxil antisickling agent) v/as prepared by pipetting 0.41 ml 
of the stock HbA solution (24.4 ixU) into a 10 ml volumetric flask. 
Using a 10 A*. 1 pipet (pipet with removable 10 ul tip), 10 A.1 of the 
1.0 mil antisickling agent solution v/as pipetted into the same 
volumetric flask. The solution in the flask was diluted to the 
mark with the buffer solution (for error analysis see appendix). 
Deoxygenation was performed by pipetting 3.0 ml of the HbA plus 
antisickling agent solution into a clean dry cell. 0.003 grams of 
sodium dithionite were added to it. The top was placed on the cell 
and it was shaken until all of the sodium dithionite dissolved in 
the solution. All other ratios v/ere prepared using a similar 
procedure. 
Soectroohotometer 
The absorption and CD spectra of deoxy-HbA were scanned from 
600nm to 400nm. In this region, the spectra were not affected by 
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the addition of sodium dithionite. However, stable spectra were 
not obtained at once. Stable spectra were obtained after about 
fifteen minutes. To insure that the spectra were stable, all 
spectra were taken about thirty minutes after the addition of 
sodium dithionite to the solution. 
The absorption measurements were done on a Varian Gary Model 
17 Automatic Recording Spectrophotometer. Difference spectra were 
obtained by placing a cell which contained a solution of deoxy- 
HbA plus the antisickling agent in the sample compartment and a 
cell containing the deoxy-HbA solution in the reference compart¬ 
ment. In the region between 600nm to 500nra, the deoxy-HbA concen¬ 
tration was 10 ILU while between 500nm to 4-OOnm the concentration 
was 1.0uH. The circular dichroism measurements were done on a 
Jasco Model S3-20 Spectropolarimeter interfaced to a Hicolet Model 
535 Signal Averager. The deoxy-HbA concentration was 10 xtM. 
RESULTS 
Absorption 
For deoxy-HbA, the Soret peak (430nm) was approximately ten 
times stronger than the visible peak (555nm). The absorption 
spectra were measured by varying the antisickling agent concen¬ 
tration while keeping the deoxy-HbA concentration constant. 
Absorption spectra were measured by first running deoxy-HbA versus 
the blank and then running deoxy-HbA plus the antisickling agent 
versus the blank. The difference spectra were measured by running 
deoxy-HbA plus the antisickling agent versus deoxy-HbA. 
Absorption and difference spectra of deoxy-HbA plus butyl- 
urea were measured using concentration ratios ( [butylureâ] / (deoxy- 
HbA]) of 1, 10, 100, 1000 and 5000. The absorption spectra show 
small changes at the absorption maxima (Fig. 6). From the 
difference spectra, the difference in absorption (AA) of deoxy-HbA 
and deoxy-HbA plus butylurea UA=absorption of deoxy-HbA— absorp¬ 
tion of.deoxy-HbA and butylurea) at the absorption maxima is plotted 
against the concentration ratios. The result are shown in Fig. 7 
for the Soret peak and Fig. 8 for the visible peak. In the figures, 
the symbols -, x, and o represent the results when the experiment 
v/as repeated tiiree different times. A different result was obtained 
each time the experiment was repeated, ie., in Fig. 7 at a concen¬ 
tration ratio of 1, AA=-0.023 for the 1st experiment (-), the 2nd 
experiment (x) AA=-0.010 and the 3rd experiment (o) AA-=-0.05^ which 
26 
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Figure 6. Absorption spectra of deoxy-HbA plus butylurea. Deoxy- 
HbA concentration was 1.0 AW between 4C0nm to 500nni and 10 AI.I 
between 500nm to 600nm.  , deoxy-HbA; , [butylurea]/ [deoxy- 
HbA] =• 1; -O-, [[butylurea]/[deoxy-HbA] = 10; , [butylurea]/ 
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Ratio ( Qîutylurea]/ [peoxy-jibAj ) 
Figure 7 » A plot of AA versus concentration ratios for deoxy- 
HbA plus butylurea at the Soret peak. The symbols -, x and o 
represent the results each time the experiment was repeated. 
-, 1st experiment; x, 2nd experiment; o, 3rd experiment. (AA 
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Ratio ( [Lut y lure A] / [Leoxy-lIbÀ] ) 
Figure 8. A plot of A A versus concentration ratios for deoxy 
HbA plus butylurea at the visible peak. -, 1st experiment," x 
2nd experiment; o, 3rd experiment. 
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is different from the first two experiments. The absorption and 
difference spectra of deoxy-HbA plus methylurea were measured 
using concentration ratios of 1, 10, 100, 1000, 5000 and 10000. 
The absorption spectra for the ratios 1, 10 and 100 are shown in 
Fig. 9. A plot of A A versus concentration ratios is shown in Fig. 
10 for the Soret peak and Fig. 11 for the visible peak. As shown 
in Fig. 10 and Fig. 11, a different result was obtained when the 
experiment was repeated. 
At first, it was suggested that the deoxy-HbA concentrations 
were different in the deoxy-HbA solution and in the deoxy-HbA 
plus the antisickling agent solution. Experiments were performed 
using the same HbA batch solution. From the 1.0 Ull HbA solution 
in the 10 ml volumetric flask, 3.0 ml of this solution was pipetted 
into a 1.0 cm cell and another 3.0 ml was pipetted into a different 
cell. To each cell, 3.0 milligrams of sodium dithionite were 
weighed out and added to it. The absorption of the deoxy-HbA 
solution in one cell was measured and the absorption of the deoxy- 
HbA solution in the other cell was measured. The absorption 
maxima of the two deoxy-HbA solutions did not coincide with each 
other. There was a difference in absorption of about 0.025. The 
instrument (Cary 17) has an error of tO.OOE Abs. and no error was 
found for the cells used in the experiments. Another experiment 
was performed where 3»0 milligrams addition of sodium dithionite 
were weighed out and repeatly added to the same cell containing 
HbA solution. The absorption was measured after each 3.0 milli- 
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X (nm) 
Figure 9. Absorption spectra of deoxy-HbA plus raethylurea. Deoxy- 
HbA concentration was l.OxU.l between AOCnm to 500nm and 10 XUvI 
between 500nra to éOOnra.   , deoxy-HbA; , Qnethylurea]/[deoxy- 
HbA] ^ 1; -0-, [methylurea] / [deoxy-HbA-] —10; ——, [methylurea]/ 
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Figure 10. A plot of AA versus concentration ratios for deoxy 
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10000 
Figure 11. A plot of AA versus concentration ratios for deoxy- 
HbA plus methylurea at the visible peak. -, 1st experiment; x, 
2nd experiment. 
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grams addition of sodium dithionite. The absorption spectra showed 
a steady decrease in absorption at the absorption maxima of about 
0.025 units. Also, repeatable results were obtained when the 
absorption of HbA without sodium dithionite was measured. This 
indicated that the inconsistent results were not caused by the pre¬ 
paration of the deoxy-HbA solutions, but that the addition of 
sodium dithionite to the HbA solution might be a factor for the 
inconsistent results, other experiments such as changing the pH 
and increasing the buffer concentration were performed, and 
differences still occurred at the absorption maxima when the 
absorption spectra were measured using the same HbA-sodium 
dithionite solution. 
18 
It was reported by Dalziel and O'Brien' that spectral changes 
at the absorption maxima of a dilute HbA-sodium dithionite solution 
were induced by brief exposure to oxygen. In some experiments, the 
contact with air was completely eliminated by adding sodium 
dithionite to the HbA solution under a nitrogen atmosphere. Cells 
containing the same HbA batch solution with equal amounts of sodium 
dithionite added to it under nitrogen also showed differences at 
the absorption maxima. 
The absorption and difference spectra of deoxy-HbA plus sodium 
cyanate showed small changes at the absorption maxima. The results 
were not repeatable (Fig. 12 and 13). When [sodium cyanate] / [deoxy- 
HbA] equals 10C0 or greater, the Boret peak at 430nm shifts to 4lfnm 
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Ratio ([Sodium Cyanate]/[peoxy-HbA] ) 
Figure 12. A plot of AA versus concentration ratios for deoxy- 
HM plus sodium cyanate at the Soret peak. -, 1st experiment; 
x, 2nd experiment. 
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Figure 13. A plot of A A versus concentration ratios for deoxy- 
HbA plus sodium cyanate at the visible peak. -, 1st experiment» 




Figure 14. Absorption 
spectra of deoxy-HbA plus 
sodium cyanate in the 
Soret region. Deoxy-HbA 
concentration was 1.0 AM. 
  , deoxy-HbA,* , 
LNaCNQ]/[deoxy-HbA] = 1000; 
— o—, Q'iaCHüD/(deox_y-HbA3 — 
5000; ——, Q-^aCliOj/[deoxy- 




Figure 15. Absorption spectra of deoxy-HbA plus sodium cyanate in 
the visible region. Deoxy-HbA concentration was 10 xui.  , 
deoxy-HbA ; , QiaCHOll/ [deoxy-HbAj = 100 ; -o-f QiaCNO]/[deoxy-HbA] 
— 1000; , Q'iaCHOj/ [deoxy-HbAj —5000. 
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pea*: at 430nm. ±n the visible region, the peak at 555nm dis- 
appears and trwo peak at 5^Qnr|i and 570nm appear (Fig. 15)* 
Circular Dichroism 
The CD spectrum of deoxy-HbA shows a positive ellipticity in 
CL 9 
the Soret region at 430nm with a value of 56.9 x 10^ deg cm /ml 
heme. Only one peak appears in the visible region as a broad 
peal: near 555nm. It has a positive ellipticity with a value of 
15.0 x 10^ deg cm^/ml heme. CD spectra were measured using the 
antisickling agents butylurea and sodium cyanate at concentration 
ratios of 100, 1000 and 5000. 
The CD spectra of deoxy-HbA plus butylurea is shown in fig. 
l6. Doth the foret and visible peaks decrease in ellipticity. 
Fig. 17 shows the CD spectra of deoxy-HbA plus sodium cyanate. 
The foret and visible peaks dcrease in ellipticity. At a ratio 
of 5000, the Soret peak shifts from 430nm to 420nm and the 420nm 
peal: has a lower intensity than the deoxy-HbA peak at 430nm. In 
the visible region, the broad peak near 555^m disappears while 
peaks at 530nm and 570nm appear on the CD spectrum. 
£j§ 
[0] X 10-5 (deg cm^/ml heme) 
i 
^0 
Figure 17. CD spectra of deoxy-H^A ulus sodium cyanate. Deoxy-KbA concentration was 
Ici Tl,I. Z , deoxy-KbA ; , JjlaCNOj/ (deoxy-HbA) —100; -0-, CKaCKOj/ (deoxy-HbAj — 
1000; , QNaCnGj/[aeoxy-HbA] = 5000. 
1) Lb CUSS I Oft 
The peaks in the region 600nm to 400nrn are associated with 
the heme group. In the Soret region, the peak is essentially a 
pure fT-Tr^ transition while the visible peaks have some charge trans¬ 
fer character from the porphyrin to the iron atom. The heme groups 
are closely connected to the ^^Z con’tac’k region. In the tran¬ 
sition from the deoxy-(unligated) to the oxy-(ligated) form of 
hemoglobin, the profound movement of the and subunits affects 
the environment of the heme groups. Thus, a change in absorption 
of these peaks would represent a change in the heme environment 
and it might suggest a change in the <X-^ contact region. 
The absorption and CD studies of deoxy-HbA in the presence of 
the alkylureas showed small changes at the absorption maxima and 
the CD extrema. However, the extent of these changes caused by 
the alkylureas could not be determined since experiments shov/ed 
that using the same HbA batch solution with the same amount of 
sodium dithionite in different cells caused small differences at 
the absorption maxima. The difference at the absorption maxima 
caused by the addition of sodium dithionite to the HbA solution 
was about 0.025 units. Since the absorption spectra of deoxy-HbA 
in the presence of the alkylureas show changes at the absorption 
maxima that were less than 0.090, a large percentage of the change 
could be caused by sodium dithionite. Also, the addition of 
sodium dithionite to the HbA solution was a factor for the incon¬ 
sistent results since repeatable results were obtained when the 
42 
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absorption of the lib A solution without sodium dithionitc was 
measured. 
The absorption measurements showed that when sodium cyanate 
was added to deoxy-HbA at a concentration ratio of 1000 and greater, 
a shift in wavelength occurs in the Soret region and two peaks 
appear in the visible region. This also occurred in the CD 
spectrum of deoxy-HbA plus sodium cyanate but at a concentration 
ratio of 5000, In the absorption spectrum, these peaks occurred 
at 4l9nm, 5^0nm, 570nm while in the CD spectrum, they occurred at 
420nm, 530nm and 570nm. Several hemoglobin derivatives have peaks 
that almost correspond in wavelength v/ith these peaks, Oxyhemo¬ 
globin has peaks at 4l9nm, 54lnm, 577nm; carboxyhemoglobin has 
peaks at 4l9nm, 54lnm, 5ô9nm; and ferrihemoglobin cyanide has peaks 
at 4l8nm and 5^1nm. J In the absorption spectrum, oxyhemoglobin 
and ferrihemoglobin cyanide have a Soret peak with a lower inten¬ 
sity than the deoxy-HbA Soret peak. In Fig, 14, the peak at 4l9nm 
has a higher intensity than the deoxy-HbA Soret peak and also the 
two visible peaks have equal intensity. For oxyhemoglobin, the 
peak at 577nm has a slightly higher intensity than the peak at 
5 4 lnm while ferrihemoglobin cyanide has only one peak in the 
visible region. On the other hand, carboxyhemoglobin has a Soret 
peak v/ith a higher intensity than deoxy-HbA Soret peak and two 
peaks in the visible region have equal intensity. Another 
possibility is that the excess I ICO” might bind directly to the 
iron atom of the heme group. 
In conclusion, it appears that sodium dithionite which was 
used to convert the HbA solution (75^ met-HbA) to deoxy-HbA was 
a major factor for the inconsistent results. Since the results 
were not repeatable, it could not be determined whether or not 
the alkylurea antisickling agents cause a conformational change. 
For sodium cyanate at a concentration ratio of 1000 or greater, a 
shift in wavelength occurs in the Soret region and two peaks appear 
in the visible region. These changes might suggest a conformational 
change for deoxy-HbA. Also in the region 400nm to 200nm, sodium 
dithionite affects the spectrum which made it impossible to study 
the effect that the antisickling agents have on the secondary 
structure of deoxy-HbA using circular dichroism. It is recommended 
that future work be done using a different method for the deoxy¬ 
genation of HbA. 
APPEND IA 
ERROR ANALYSIS 
Pipets (Fisher brand) 
1.0 ml in l/lOO 
5.0 ml in l/lO 
2.0 ml 
3.0 ml 
Volumetric flask (Pyrex) 
10 ml ± 0.020 ml 
25 ml ±0.030 ml 
50 ml ±0.050 ml 
100 ml ±0.080 ml 
250 ml ±0.120 ml 
1000 ml ±0.300 ml 
Scale ±0.00001 gram 
Cells (1.0 cm) ±0.00 
Spectrophotometer (Cary 1?) t0.00k Abs. 






Propagation of Errors for Solutions 
M = raole/liter 
M — gram/mole wt.* liter 
a mole wt. 
CS, 'gram 
Ce¬ nter 





?(mole wt.) ^mole wt. 
AAL 
à(liter) ‘i iter + 
D11. 
3 (gram) gram 
Buffer solution 
Tris (0.11*1) 0^—4 x lO”-5; 
EDTA (l.OmOl) 0-^—4 x 10”^ j 
0.1 ±4 x 10~5il 
1.0 44 x 10""^mil 
Antisickling agents solutions 
Methylurea and Sodium Cyanate 
1. Omlî — 1 X 10-6 1.0 ±l X 10“3mlvl 
50mM 
°I,I 
= 6 X 10"5 50 ±6 X 10”2mlvl 









1. OmW ai,I — 2 X 10“
6 1.0 ±2 ■y 10“3mM 
















0.5 ±5 X 10“/+M 
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HbA (stock-24.4/*M) 











cell path length error 
^C_ 0. A 
3 A 
24.4 ±1.2 
Solution for spectral studies 
Mlvl “ H2V2 
M, :IlVvX 
1, = 





a V- : flask error 
3 ii-| 
S + 
3 O'., d 











= 1 X 





V2 ~volurae of 
solution pipetted 
Ivlp — solution con¬ 
centration 
v1 — flask volume 
Antisickling agent (l.OmM methylurea; HbA —l.OwH) 




The appendix gives an error analysis for the experimental result. 
A 24.4 AM stock HbA solution had an error of about 15%. The stock 
antisickling agents solutions had errors ranging from 0.07# to 
0.1%. For the absorption experiments, there is a .5-1% error for 
the visible peak and a 5-10% error for the Soret peak. Thus there 
is a 5-10# error for the visible peak and a 50-100# error for the 
Soret peak for the A A experiments. 
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